Europe - FRA:DAP - US2358511028 - Common Stock
Taking everything into account, DAP scores 6 out of 10 in our fundamental rating. DAP was compared to 20 industry peers in the Life Sciences Tools & Services industry. DAP has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. While showing a medium growth rate, DAP is valued expensive at the moment.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 4.18% | ||
ROE | 6.52% | ||
ROIC | 5.32% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 19.79% | ||
PM (TTM) | 14.21% | ||
GM | 59.72% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.32 | ||
Debt/FCF | 3.57 | ||
Altman-Z | 4.49 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 1.62 | ||
Quick Ratio | 1.22 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 28.66 | ||
Fwd PE | 24.9 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 31.8 | ||
EV/EBITDA | 23.67 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 0.61% |
FRA:DAP (10/3/2025, 7:00:00 PM)
184
+2.82 (+1.56%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 0.61% |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 28.66 | ||
Fwd PE | 24.9 | ||
P/S | 6.44 | ||
P/FCF | 31.8 | ||
P/OCF | 25.06 | ||
P/B | 2.95 | ||
P/tB | N/A | ||
EV/EBITDA | 23.67 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 4.18% | ||
ROE | 6.52% | ||
ROCE | 6.35% | ||
ROIC | 5.32% | ||
ROICexc | 5.54% | ||
ROICexgc | 38.86% | ||
OM | 19.79% | ||
PM (TTM) | 14.21% | ||
GM | 59.72% | ||
FCFM | 20.25% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.32 | ||
Debt/FCF | 3.57 | ||
Debt/EBITDA | 2.36 | ||
Cap/Depr | 54.73% | ||
Cap/Sales | 5.44% | ||
Interest Coverage | 13.86 | ||
Cash Conversion | 86.39% | ||
Profit Quality | 142.46% | ||
Current Ratio | 1.62 | ||
Quick Ratio | 1.22 | ||
Altman-Z | 4.49 |